Drugmakers engaged in price-fixing cover-up, lawsuit claims
(By Alia Paavola for Becker’s Hospital Review) A wide-reaching lawsuit unsealed June 24 claims Teva Pharmaceuticals, subsidiaries of Pfizer and
Read More
Part D/Prescription Drugs
How Many Medicare Part D Enrollees Had High Out-of-Pocket Drug Costs in 2017?
(By Juliette Cubanski, Tricia Neuman, And Anthony Damcio for Kaiser Family Foundation) The Medicare Part D prescription drug benefit has
Read MoreSurgeons’ Opioid-Prescribing Habits Hard To Kick
(By Julie Appleby and Elizabeth Lucas for Kaiser Health News) As opioid addiction and deadly overdoses escalated into an epidemic
Read MoreFederally funded research drives nearly one-third of U.S. patents, report finds
(By Brittany Flaherty for STAT) As researchers bemoan cuts in federal funding for basic science, a new study of millions
Read MoreSome seniors will get a surprise Medicare bill soon
According to a news report, at least 250,000 seniors may soon receive a bill for up to five months of
Read MoreMedicare Part A is typically free for enrollees, but that’s only one piece of the overall puzzle
Think of Medicare as a puzzle; it is made up of several distinct parts: Parts A, B, C, and D.
Read More10 most expensive drugs in US
(By Alia Paavola for Becker’s Hospital Review) Zolgensma, recently approved by the FDA, tops GoodRx’s list of the 10 most
Read MoreGSK partners with CRISPR pioneer Doudna to search for new drugs
(By Matthew Herper for STAT) SAN FRANCISCO — The drug maker GlaxoSmithKline announced Thursday that it would team up with
Read MoreSenators want to know if HHS money went to Chinese genomics firms
(By Damian Garde for STAT) Two Republican senators are asking whether the Department of Health and Human Services might have
Read MoreTeva expands nationwide recall of losartan
(By Alia Paavola for Becker’s Hospital Review) Teva Pharmaceuticals has recalled an additional six lots of bulk losartan potassium tablets,
Read More